Home › Research › Topics › emergence
emergence
3 studies tagged emergence, dated 2019-11-01 to 2025-02-19. Bibliography: BibTeX (.bib) · RIS (.ris)
Newest in this topic
- GLP-1 receptor agonists, are we witnessing the emergence of a paradigm shift for neuro-cardio-metabolic disorders? 2025-02-19
- An Update of the Treatment Landscape for Alzheimer's Disease: From Symptomatic Treatments to the Emergence of Amyloid-Targeting Therapies 2025-01-01
- The Potential Emergence of Disease-Modifying Treatments for Alzheimer Disease: The Role of Primary Care in Managing the Patient Journey 2019-11-01
Studies
3 studies carry this tag.
Date range
2019 to 2025
Top journals
- Journal of the American Board of Family Medicine : JABFM 1
- Pharmacology & therapeutics 1
- Sage open aging 1
Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.
-
Glucagon-like peptide-1 receptor agonists (GLP-1RAs) have emerged as groundbreaking therapeutic agents in managing a spectrum of metabolic disorders, demonstrating remarkable efficacy across multiple organ systems and disease states.
-
Several approved Alzheimer's disease (AD) treatments help manage its associated cognitive symptoms (e.g., donepezil and memantine) or non-cognitive symptoms.
-
Despite recent setbacks, disease-modifying treatments (DMTs) for Alzheimer disease (AD) might become available within a few years.